GSK3 INHIBITORIAI IR JŲ PANAUDOJIMO BŪDAI

• 收藏
• 分享

专利权人:

The Broad Institute, Inc.;Dana-Farber Cancer Institute, Inc.;The General Hospital Corporation

发明人:

WAGNER, Florence,PAN, Jennifer,DANDAPANI, Sivaraman,GERMAIN, Andrew,HOLSON, Edward,MUNOZ, Benito,NAG, Partha,WEIWER, Michel,LEWIS, Michael,HAGGARTY, Stephen,BISHOP, Joshua,STEGMAIER, Kimberly,BANERJI,

申请号：

LT13780300

公开号：

LT2909204T

申请日:

2013.10.11

申请国别(地区):

LT

年份:

2019

代理人:

摘要：

The present invention provides compounds of formula I, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting kinase (e.g., GSK3 (e.g., GSK3&alpha； or GSK3&bgr；) or CK1) activity. The present invention further provides methods of using the compounds described herein for treating kinase-mediated disorders, such as neurological diseases, psychiatric disorders, metabolic disorders, and cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/